Welcure Drugs & Pharmaceuticals Ltd. - Research Center
524661 WELCURE Group (X) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | - | - | 0.08 | 0.02 | 0.08 |
| Operating profit | -0.12 | -0.07 | 0.06 | -0.04 | 0.02 |
| Interest | - | - | - | - | - |
| Gross profit | -0.12 | -0.06 | 0.06 | -0.04 | 0.02 |
| EPS (Rs) | -0.10 | -0.05 | 0.05 | -0.03 | 0.02 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | - | 0.01 | - | - | - |
| Stock adjustment | - | - | - | - | - |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.03 | 0.01 | 0.01 | 0.01 | - |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.09 | 0.06 | 0.01 | 0.05 | 0.06 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.01 | - | - | - | - |
| Taxation | - | - | - | - | - |
| Net profit / loss | -0.13 | -0.06 | 0.06 | -0.04 | 0.02 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 13.44 | 13.44 | 12.12 | 12.12 | 12.12 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | - | - | 74.06 | -166.67 | 22.88 |
| GPM (%) | - | - | - | - | 23.44 |
| NPM (%) | - | - | - | - | 23.44 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis